解整合素金屬蛋白酶28(ADAM28)重組蛋白
Recombinant A Disintegrin And Metalloprotease 28 (ADAM28)
ADAM23; MDCL; eMDCII; Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L; Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II
- 編號URPK202Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位細(xì)胞膜
- 預(yù)測分子量29.3kDa
- 實(shí)際分子量34kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Glu525~Lys774 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 97%
- 等電點(diǎn)7.5
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 516 ¥ 1290 ¥ 2580 ¥ 7740 ¥ 19350
- 欲了解實(shí)際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Figure . Gene Sequencing (extract)
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.25 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPK202Hu01 | 解整合素金屬蛋白酶28(ADAM28)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAK202Hu01 | 解整合素金屬蛋白酶28(ADAM28)多克隆抗體 | WB; IHC; ICC; IP. |
| UMAK202Hu21 | 解整合素金屬蛋白酶28(ADAM28)單克隆抗體 | WB; IHC; ICC; IP. |
| USEK202Hu | 解整合素金屬蛋白酶28(ADAM28)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMK202Hu | 解整合素金屬蛋白酶28(ADAM28)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Rapid Communications in Mass Spectrometry | Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma [Pubmed: 21913264] |
| Medical Oncology | Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor [SpringerLink: kg628446760r60rl] |
| Immunology & Cell Biology | ADAM28 is elevated in humans with the metabolic syndrome and is a novel sheddase of human tumour necrosis factor-α. [PubMed: 23010875] |
| Leuk Res | ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in [PubMed: 26340916] |
| Disease Markers | Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results [Pubmed: 31565100] |
留言咨詢
